Arxis Inc. said it expects to sell about 37.7 million shares priced between $25 and $28 each.
A Bloomfield-based industrial manufacturer that includes Kaman Corp.’s operations and supplies parts used in aircraft, defense systems and medical devices has set terms for its planned initial public offering, signaling a potential multibillion-dollar market debut.
Arxis Inc. said in an updated filing with the U.S. Securities and Exchange Commission that it expects to sell about 37.7 million shares priced between $25 and $28 each. The offering could raise between about $940 million and $1.06 billion, based on the proposed price range.
At the top end, the company could be valued at roughly $11 billion.
The company,
which previously filed to go public without disclosing pricing, plans to list its shares on the Nasdaq under the ticker symbol “ARXS.”
Arxis said it expects to use proceeds from the offering primarily to pay down debt and for general corporate purposes.
The filing also provides new detail on the company’s ownership structure. Private equity firm Arcline Investment Management is expected to retain control following the IPO through a dual-class share structure that will give it a significant majority of voting power.
Arxis was formed in October 2025 to combine a group of industrial businesses assembled by Arcline, including Kaman and other specialized component manufacturers. The company produces engineered components used in aerospace, defense, medical and industrial applications.
Arxis reported about $1.6 billion in revenue and $46 million in net income in 2025, according to its filing.
